Table 4 Univariate analysis of sociodemographic characteristics among the profiles (n, %).

From: Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors

Variables

Potential profile group

χ2

P-value

Low-risk

Fear group (n = 95) (%)

Moderate-risk

Fear group (n = 249) (%)

High-risk

Fear group (n = 111) (%)

FoP-Q-SF

Yes

15(15.79)

137(55.02)

103(92.79)

123.454

< 0.01

No

80(84.21)

112(44.98)

8(7.21)

Gender

Male

68(71.58)

122(49.00)

57(51.35)

14.645

< 0.01

Female

27(28.42)

127(51.00)

54(48.65)

Age (at the time of the survey, years)

< 35

44(46.32)

74(29.72)

17(15.32)

33.432

< 0.01

35 ~ 65

48(50.53)

153(61.45)

72(64.86)

> 65

3(3.16)

22(11.65)

22(19.82)

Marital status

Unmarried

45(47.37)

29(18.47)

10(9.01)

25.132

< 0.01

Married

50(52.63)

189(75.90)

84(75.68)

Divorced

0(0.00)

22(8.84)

13(11.71)

Bereaved

0(0.00)

9(3.61)

4(3.60)

Education

Primary school or lower

0(0.00)

17(10.00)

15(17.24)

39.468

< 0.01

Junior high school

13(13.68)

70(28.11)

37(33.33)

High school or vocational school

21(22.11)

63(25.30)

29(26.13)

Academic degree or college school

50(52.63)

79(31.73)

24(21.62)

Master’s degree or higher

11(11.58)

20(8.03)

6(5.41)

Monthly per capita household income (CNY, yuan)

< 3000

26(27.37)

122(49.00)

59(53.15)

17.363

< 0.01

3000 ~ 5000

40(42.11)

73(29.32)

34(30.63)

> 5000

29(30.53)

54(21.69)

18(16.22)

Employment status

Full time job

37(38.95)

61(24.50)

19(17.12)

23.254

< 0.01

Part-time job

2(2.11)

11(4.42)

3(2.70)

Retain the job but suspend the salary

9(9.47)

13(5.22)

9(8.11)

Retirement

13(13.68)

55(22.09)

37(33.33)

Unemployed

34(35.79)

109(43.78)

43(38.74)

Diagnosis

Leukemia

62(65.26)

144(57.83)

41(36.94)

23.946

< 0.01

Lymphoma

25(26.32)

77(30.92)

43(38.74)

MDS

6(6.32)

23(9.24)

23(20.72)

Multiple myeloma

2(2.11)

5(2.01)

4(3.60)

Time since diagnosis (years)

<1

73(76.84)

189(75.90)

77(69.37)

2.169

0.705

1–5

18(18.95)

48(19.28)

28(25.23)

> 5

4(4.21)

12(4.82)

6(5.41)

Chemotherapy

Yes

6(6.32)

15(6.02)

12(10.81)

2.773

0.250

No

89(93.68)

234(93.98)

99(89.19)